Search Results - "Zanos, Panos"

Refine Results
  1. 1

    Exploring the neurofunctional impairments and cognitive biases concerning food and body related stimuli in anorexia nervosa: An integrated EEG and eye-tracking study protocol by Loizou, Panagiotis, Panagiotou, Georgia, Zanos, Panos, Paraskevopoulos, Evangelos

    Published in PloS one (28-03-2024)
    “…Patients with Anorexia Nervosa (AN) exhibit significant cognitive and neural disturbances compared to healthy individuals when processing food and body-related…”
    Get full text
    Journal Article
  2. 2

    Group II metabotropic glutamate receptor blockade promotes stress resilience in mice by Highland, Jaclyn N, Zanos, Panos, Georgiou, Polymnia, Gould, Todd D

    Published in Neuropsychopharmacology (New York, N.Y.) (01-09-2019)
    “…Stress is a leading risk factor for the onset and recurrence of major depression. Enhancing stress resilience may be a therapeutic strategy to prevent the…”
    Get full text
    Journal Article
  3. 3

    One path, two solutions: Network-based analysis identifies targetable pathways for the treatment of comorbid type II diabetes and neuropsychiatric disorders by Onisiforou, Anna, Zanos, Panos

    “…Comorbid diseases complicate patient outcomes and escalate healthcare costs, necessitating the need for a deeper mechanistic understanding. Neuropsychiatric…”
    Get full text
    Journal Article
  4. 4

    Convergent Mechanisms Underlying Rapid Antidepressant Action by Zanos, Panos, Thompson, Scott M., Duman, Ronald S., Zarate, Carlos A., Gould, Todd D.

    Published in CNS drugs (01-03-2018)
    “…Traditional pharmacological treatments for depression have a delayed therapeutic onset, ranging from several weeks to months, and there is a high percentage of…”
    Get full text
    Journal Article
  5. 5

    Molecular signatures of premature aging in Major Depression and Substance Use Disorders by Onisiforou, Anna, Zanos, Panos, Georgiou, Polymnia

    Published in Scientific data (26-06-2024)
    “…Major depressive disorder (MDD) and substance-use disorders (SUDs) often lead to premature aging, increasing vulnerability to cognitive decline and other forms…”
    Get full text
    Journal Article
  6. 6

    (2R,6R)-hydroxynorketamine rapidly potentiates hippocampal glutamatergic transmission through a synapse-specific presynaptic mechanism by Riggs, Lace M, Aracava, Yasco, Zanos, Panos, Fischell, Jonathan, Albuquerque, Edson X, Pereira, Edna F R, Thompson, Scott M, Gould, Todd D

    Published in Neuropsychopharmacology (New York, N.Y.) (01-01-2020)
    “…Preclinical studies indicate that (2R,6R)-hydroxynorketamine (HNK) retains the rapid and sustained antidepressant-like actions of ketamine, but is spared its…”
    Get full text
    Journal Article
  7. 7

    Synthesis and N‑Methyl‑d‑aspartate (NMDA) Receptor Activity of Ketamine Metabolites by Morris, Patrick J, Moaddel, Ruin, Zanos, Panos, Moore, Curtis E, Gould, Todd, Zarate, Carlos A, Thomas, Craig J

    Published in Organic letters (01-09-2017)
    “…Ketamine is rapidly metabolized in the human body to a variety of metabolites, including the hydroxy­norketamines. At least two hydroxy­norketamines have…”
    Get full text
    Journal Article
  8. 8

    The impact of estradiol on serotonin, glutamate, and dopamine systems by Bendis, Peyton Christine, Zimmerman, Sydney, Onisiforou, Anna, Zanos, Panos, Georgiou, Polymnia

    Published in Frontiers in neuroscience (2024)
    “…Estradiol, the most potent and prevalent member of the estrogen class of steroid hormones and is expressed in both sexes. Functioning as a neuroactive steroid,…”
    Get full text
    Journal Article
  9. 9

    Psychological stress enhances tumor growth and diminishes radiation response in preclinical model of lung cancer by Zhang, Yi, Zanos, Panos, Jackson, Isabel L., Zhang, Xiuwu, Zhu, Xiongzhao, Gould, Todd, Vujaskovic, Zeljko

    Published in Radiotherapy and oncology (01-05-2020)
    “…•Psychological stress-induced depression increased tumor growth and radioresistance.•Psychological stress activates epithelial-mesenchymal transition…”
    Get full text
    Journal Article
  10. 10

    Classical conditioning of antidepressant placebo effects in mice by Krimmel, Samuel R., Zanos, Panos, Georgiou, Polymnia, Colloca, Luana, Gould, Todd D.

    Published in Psychopharmacology (01-01-2020)
    “…Introduction Placebo effects in human clinical trials for depression treatment are robust and often comparable to drug effects. Placebo effects are…”
    Get full text
    Journal Article
  11. 11

    Sex-dependent metabolism of ketamine and (2R,6R)-hydroxynorketamine in mice and humans by Highland, Jaclyn N, Farmer, Cristan A, Zanos, Panos, Lovett, Jacqueline, Zarate, Carlos A, Moaddel, Ruin, Gould, Todd D

    Published in Journal of psychopharmacology (Oxford) (01-02-2022)
    “…Background: Ketamine is rapidly metabolized to norketamine and hydroxynorketamine (HNK) metabolites. In female mice, when compared to males, higher levels of…”
    Get full text
    Journal Article
  12. 12

    Transcriptomic analysis reveals sex-specific patterns in the hippocampus in Alzheimer's disease by Onisiforou, Anna, Christodoulou, Christiana C, Zamba-Papanicolaou, Eleni, Zanos, Panos, Georgiou, Polymnia

    Published in Frontiers in endocrinology (Lausanne) (16-04-2024)
    “…The hippocampus, vital for memory and learning, is among the first brain regions affected in Alzheimer's Disease (AD) and exhibits adult neurogenesis. Women…”
    Get full text
    Journal Article
  13. 13

    Unraveling the transcriptomic signatures of Parkinson’s disease and major depression using single-cell and bulk data by Christodoulou, Christiana C., Onisiforou, Anna, Zanos, Panos, Papanicolaou, Eleni Zamba

    Published in Frontiers in aging neuroscience (07-11-2023)
    “…Background Motor symptoms are well-characterized in Parkinson’s disease (PD). However, non-motor symptoms, such as depression, are commonly observed and can…”
    Get full text
    Journal Article
  14. 14

    Target deconvolution studies of (2R,6R)-hydroxynorketamine: an elusive search by Bonaventura, Jordi, Gomez, Juan L., Carlton, Meghan L., Lam, Sherry, Sanchez-Soto, Marta, Morris, Patrick J., Moaddel, Ruin, Kang, Hye Jin, Zanos, Panos, Gould, Todd D., Thomas, Craig J., Sibley, David R., Zarate, Carlos A., Michaelides, Michael

    Published in Molecular psychiatry (01-10-2022)
    “…The off-label use of racemic ketamine and the FDA approval of (S)-ketamine are promising developments for the treatment of depression. Nevertheless, racemic…”
    Get full text
    Journal Article
  15. 15

    Mouse, rat, and dog bioavailability and mouse oral antidepressant efficacy of (2R,6R)-hydroxynorketamine by Highland, Jaclyn N, Morris, Patrick J, Zanos, Panos, Lovett, Jacqueline, Ghosh, Soumita, Wang, Amy Q, Zarate, Carlos A, Thomas, Craig J, Moaddel, Ruin, Gould, Todd D

    Published in Journal of psychopharmacology (Oxford) (01-01-2019)
    “…Background: (R,S)-ketamine has gained attention for its rapid-acting antidepressant actions in patients with treatment-resistant depression. However,…”
    Get full text
    Journal Article
  16. 16

    Investigating the shared genetic basis and causal relationships between mucosa-associated lymphoid tissue inflammation and psychiatric disorders by Georgiou, Andrea N, Voskarides, Konstantinos, Zanos, Panos, Chatzittofis, Andreas

    Published in Frontiers in psychiatry (2024)
    “…Chronic and acute inflammation of the mucosa-associated lymphoid tissue have been positively linked to the development of psychiatric disorders in…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    Sex-Specific Involvement of Estrogen Receptors in Behavioral Responses to Stress and Psychomotor Activation by Georgiou, Polymnia, Zanos, Panos, Jenne, Carleigh E, Gould, Todd D

    Published in Frontiers in psychiatry (26-02-2019)
    “…Fluctuating hormone levels, such as estradiol might underlie the difference in the prevalence of psychiatric disorders observed in women vs. men. Estradiol…”
    Get full text
    Journal Article
  20. 20